Kirjoita osake tai kryptovaluutta hakupalkkiin saadaksesi yhteenvedon
China Shineway Pharmaceutical Group Ltd
CSWYFChina Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese medicines in the People's Republic of China and Hong Kong. The company offers Chinese medicines in the form of injection, soft capsules, and granules; tablets, pills, oral liquid, and powder; and traditional Chinese medicine granules in various therapeutic areas, including respiratory system disease, nervous system, digestive system disease, cardiovascular and cerebrovascular, orthopedics, pediatrics, and other areas, as well as medication for strengthening the body. It is also involved in the trading of agricultural products; and research and development of Chinese pharmaceutical products. The company was incorporated in 2002 and is headquartered in Shijiazhuang, the People's Republic of China. China Shineway Pharmaceutical Group Limited operates as a subsidiary of BH Corporate Services Ltd. Address: No. 168, Shiluan Street, Shijiazhuang, China, 051430
Analytics
WallStreetin tavoitehinta
115.51 HKDP/E-suhde
6.0818Osinkotuotto
5.92 %Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Avainluvut CSWYF
Osinkoanalytiikka CSWYF
Osinkojen kasvu 5 vuoden aikana
71 %Jatkuva kasvu
1 vuosiMaksusuhde 5 vuoden keskiarvo
59 %Osinkohistoria CSWYF
Osakkeen arvostus CSWYF
Talousasiat CSWYF
Tuloksia | 2019 | Dynamiikka |